By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TaiGen Biotechnology 

Nei-Hu  Taipei    Taiwan
Phone: N/A Fax:



Start Up

Company News
TaiGen Biotechnology Out-Licenses Taigexyn (Nemonoxacin) To Productos Científicos For The Latin American Market 8/25/2016 7:15:23 AM
TaiGen Biotechnology Receives Market Approval From The China Food And Drug Administration For Taigexyn (Nemonoxacin) 6/14/2016 12:41:10 PM
TaiGen Biotechnology Launches Taigexyn In Taiwan 12/16/2015 6:22:06 AM
TaiGen Biotechnology's Intravenous Taigexyn Successfully Achieved Primary Endpoint In Phase 3 Clinical Trial For Community Acquired Pneumonia 12/3/2015 6:27:20 AM
TaiGen Biotechnology Starts China Trial Of Novel Chemotherapy Sensitizer 5/1/2015 11:09:40 AM
TaiGen Biotechnology Announces Initiation of Burixafor Chemosensitization Clinical Trial In Acute Myeloid Leukemia In China 4/30/2015 6:21:40 AM
TaiGen Biotechnology Announces Burixafor Collaboration With Celldex (CLDX) And The University Hospital Carl Gustav Carus Dresden In Germany 3/18/2015 6:39:31 AM
ScinoPharm To Provide Active Pharmaceutical Ingredient To TaiGen Biotechnology For Novel Stem Cell Drug 6/9/2014 10:17:55 AM
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014 11:05:33 AM
TaiGen Biotechnology Raises $36 Million In Taiwan IPO 1/20/2014 1:44:50 PM